MEDIROM Healthcare Technologies Inc. (MRM) Earnings History
Net Loss7 years of earnings data (2018–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
MEDIROM Healthcare Technologies Inc. (MRM) Earnings Overview
As of June 28, 2026, MEDIROM Healthcare Technologies Inc. (MRM) reported trailing twelve-month net income of -$52M, reflecting +20.1% year-over-year growth. The company earned $-6.56 per diluted share over the past four quarters, with a net profit margin of 1.8%.
Looking at the long-term picture, MRM's 5-year EPS compound annual growth rate (CAGR) stands at +45.8%, indicating exceptional earnings growth. The company achieved its highest annual net income of $149M in fiscal 2022.
MEDIROM Healthcare Technologies Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including XPOF (-$33M net income, -10.7% margin), PLNT ($229M net income, 16.5% margin), MNMD (-$238M net income), MRM has outperformed on profitability metrics. Compare MRM vs XPOF →
MRM Earnings vs Peers
Earnings metrics vs comparable public companies
MRM Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $149M | +29.3% | -$18M | $26.74 | 1.8% | -0.2% |
| 2023 | $115M | -22.8% | -$392M | $22.27 | 1.7% | -5.7% |
| 2022 | $149M | +115.0% | $97M | $27.23 | 2.1% | 1.4% |
| 2021 | -$991M | -83.8% | -$471M | $-203.13 | -18.3% | -8.7% |
| 2020 | -$539M | -3210.3% | -$746M | $-133.97 | -16.1% | -22.3% |
| 2019 | $17M | -73.9% | $34M | $4.06 | 0.4% | 0.9% |
| 2018 | $66M | - | $73M | $14.04 | 1.9% | 2.1% |
Download Data
Export MRM earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MRM — Frequently Asked Questions
Quick answers to the most common questions about buying MRM stock.
What is MRM earnings per share (EPS)?
MRM trailing twelve-month (TTM) diluted EPS is $-6.56, reflecting +20.1% year-over-year growth. The 5-year EPS CAGR is +45.8%. Complete EPS history from 2018 to 2024 is available in the table on this page.
What is MEDIROM Healthcare Technologies Inc.'s net income?
MEDIROM Healthcare Technologies Inc. (MRM) trailing twelve-month net income is $-52M as of 2024. Earnings grew +20.1% year-over-year. MEDIROM Healthcare Technologies Inc. has been profitable for 3 consecutive years.
Is MRM profitable?
MRM is not currently profitable on a TTM basis, reporting a net loss of $-52M. Net margin is +1.8%. Investors should monitor for a return to profitability.
What is MRM's earnings growth rate?
MRM compound annual EPS growth rates (CAGR): 1-Year: +20.1%, 3-Year: N/A, 5-Year: +45.8%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2024.
What are MRM's profit margins?
MEDIROM Healthcare Technologies Inc. net profit margin is +1.8%, operating margin is -0.2%, and gross margin is +27.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is +21.2%.
Is MRM growing earnings?
Yes, MRM earnings are accelerating — EPS growth of +20.1% exceeds the 5-year CAGR of +45.8%. TTM net income reached $-52M. Earnings momentum is strengthening.
What was MRM's best earnings year?
MEDIROM Healthcare Technologies Inc.'s highest annual net income on record is $149M, achieved in fiscal year 2022. Earnings history on this page spans 2018 to 2024 and includes all annual and quarterly figures.
What were MRM's earnings last quarter?
MRM's most recent reported quarter was Q2 2025. Net income was $-671M with diluted EPS of $-85.10. For a full breakdown of all quarters, see the quarterly earnings table on this page.